Concepedia

Visual outcome following chemotherapy for progressive optic pathway gliomas

Ben Shofty, Liat Ben‐Sira, Sigal Freedman, Michal Yalon, Rina Dvir, Michael Weintraub, Hagit Toledano, Shlomi Constantini, Anat Kesler

Pediatric Blood & Cancer · 2011 · 65 citations · 19 references

DOI

Abstract

The majority of our patients, who received chemotherapy for progressive OPG, experienced a decline in their visual function. New, more effective treatments are needed in order to preserve vision in this group.

References

19

Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas

R. J. Packer, Jeffrey C. Allen, Peter C. Phillips∥ et al. · Journal of neurosurgery · 1997 · 632 citations

Second Primary Tumors in Neurofibromatosis 1 Patients Treated for Optic Glioma: Substantial Risks After Radiotherapy

Saba Sharif, Rosalie E. Ferner, Jillian M. Birch et al. · Journal of Clinical Oncology · 2006 · 368 citations

Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood.

Roger J. Packer, Beverly J. Lange, J Ater et al. · Journal of Clinical Oncology · 1993 · 354 citations

Spontaneous Regression of Optic Gliomas

Cameron F. Parsa · Archives of Ophthalmology · 2001 · 293 citations

Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): A retrospective study of 104 patients

Jean Sébastien Guillamo, Alain Créange, C Kalifa et al. · Brain · 2002 · 283 citations · Full text